Patent Assignment
Reel/Frame 063842/0405
Assignment of Assignor's Interest
Recorded: 2023-06-02
Pages: 58
Assignor
BERG LLC
Executed: 2023-05-24
Assignee
BPGBIO, INC.
500 OLD CONNECTICUT PATH, FRAMINGHAM, MASSACHUSETTS, 01701
Covered Properties
(73)
Protein Markers for the Prognosis of Breast Cancer Progression
PCT:
PCT/US2022/023633 ↗
Protein Markers for Estrogen Receptor (Er)-Positive Luminal a(La)-Like and Luminal B1 (LB1)-Like Breast Cancer
PCT:
PCT/US2022/023695 ↗
Protein Markers for Estrogen Receptor (Er)-Positive-Like and Estrogen Receptor (Er)-Negative-Like Breast Cancer
PCT:
PCT/US2022/023700 ↗
Compounds for Use in Treating Gastric Cancer
PCT:
PCT/US2022/050289 ↗
Topical Formulations Having Enhanced Bioavailability
Methods for Treatment of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Methods for the Diagnosis of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Vitamin D3 and Analogs Thereof for Treating Alopecia
Assay System for the Assessment of Oncogenicity, Tumor Progression, and Treatment Efficacy
INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF
Interrogatory Cell-Based Assays and Uses Thereof
Inhalable Pharmaceutical Compositions
Interrogatory Cell-Based Assays and Uses Thereof
Topical Formulations Having Enhanced Bioavailability
Methods and Kits for Detection of Coenzyme Q10
Methods of Treating a Metabolic Syndrome by Modulating Heat Shock Protein (Hsp) 90-Beta
Use of Markers in the Identification of Cardiotoxic Agents and in the Diagnosis and Monitoring of Cardiomyopathy and Cardiovascular Disease
Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10)
Methods for the Treatment of Cancer Using Coenzyme Q10 Combination Therapies
Methods of Treatment of Cancer by Continuous Infusion of Coenzyme Q10
Enolase 1 (ENO1) Compositions and Uses Thereof
Enolase 1 (ENO1) Compositions and Uses Thereof
Methods and Use of Inducing Apoptosis in Cancer Cells
Bayesian Causal Relationship Network Models for Healthcare Diagnosis and Treatment Based on Patient Data
Use of Markers Including Filamin a in the Diagnosis and Treatment of Prostate Cancer
Use of Markers in the Diagnosis and Treatment of Prostate Cancer
Method for Detection of Coenzyme Q10
Compositions Comprising ENO1 and Their Use in Methods of Treating Obesity or Overweight and Reducing Weight Gain
Application:
15/190,126 →
Publication:
US 2016/0375113
Method of Treating or Preventing Tumors of the Central Nervous System
Filamin a Binding Proteins and Uses Thereof
Methods for Treating Parkinson's Disease
Interrogatory Cell-Based Assays and Uses Thereof
Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10)
Methods of Treatment of Cancer by Continuous Infusion of Coenzyme Q10
Vitamin D3 and Analogs Thereof for Treating Alopecia
Use of Coenzyme Q10 Formulations in the Treatment and Prevention of Epidermolysis Bullosa
Interrogatory Cell-Based Assays and Uses Thereof
Methods and Kits for Detection of Coenzyme Q10
Interrogatory Cell-Based Assays for Identifying Drug-Induced Toxicity Markers
Enolase 1 (ENO1) Compositions and Uses Thereof
Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10)
Method of Treating or Preventing Tumors of the Central Nervous System
Methods for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer
Application:
16/509,808 →
Publication:
US 2020/0018758
Bayesian Causal Relationship Network Models for Healthcare Diagnosis and Treatment Based on Patient Data
Use of Markers Including Filamin a in the Diagnosis and Treatment of Prostate Cancer
Application:
16/688,266 →
Publication:
US 2020/0333344
Markers for the Diagnosis of Biochemical Recurrence in Prostate Cancer
Methods and Use of Inducing Apoptosis in Cancer Cells
Application:
16/864,220 →
Publication:
US 2021/0077424
Markers for the Diagnosis of Prostate Cancer
Application:
16/913,775 →
Publication:
US 2021/0080466
Enolase 1 (ENO1) Compositions and Uses Thereof
Application:
16/931,643 →
Publication:
US 2021/0169999
Filamin a Binding Proteins and Uses Thereof
Combination Therapy of Coenzyme Q10 and Radiation for Treatment of Glioma
Application:
17/100,674 →
Publication:
US 2021/0322339
Inhalable Pharmaceutical Compositions
Application:
17/118,229 →
Publication:
US 2021/0346291
UBE2K Modulators and Methods for Their Use
Methods for the Treatment of Cancer Using Coenzyme Q10 Combination Therapies
Application:
17/141,499 →
Publication:
US 2021/0369645
Methods for Treating Parkinson's Disease
Application:
17/225,084 →
Publication:
US 2022/0064732
Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10)
Methods of Treating Cancer by Inhibiting Ubiquitin Conjugating Enzyme E2 K (UBE2K)
Application:
17/274,405 →
Publication:
US 2021/0252036
Methods of Treatment of Solid Tumors Using Coenzyme Q10
Application:
17/321,699 →
Publication:
US 2022/0096399
Preventing or Mitigating Chemotherapy Induced Alopecia Using Vitamin D
Application:
17/341,027 →
Publication:
US 2022/0023317
Lipid, Protein, and Metabolite Markers for the Diagnosis and Treatment of Prostate Cancer
Application:
17/343,538 →
Publication:
US 2022/0107322
Methods and Systems for Identifying Modulators of Pervasive Developmental Disorders
Application:
17/346,152 →
Publication:
US 2022/0137070
UBE2K Modulators and Methods for Their Use
Application:
17/369,032 →
Publication:
US 2022/0002255
Methods for the Treatment of Cancer Using Coenzyme Q10 in Combination with Immune Checkpoint Modulators
Application:
17/376,357 →
Publication:
US 2022/0096400
Methods of Treatment of Temozolomide-Resistant Glioma Using Coenzyme Q10
Protein Markers for Estrogen Receptor (Er)-Positive-Like and Estrogen Receptor (Er)-Negative-Like Breast Cancer
Application:
17/714,778 →
Publication:
US 2023/0059578
INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF
Application:
17/836,950 →
Publication:
US 2023/0165809
Topical Formulations Having Enhanced Bioavailability
Application:
17/847,577 →
Publication:
US 2023/0147697
Coenzyme Q10 Formulations in the Treatment and Prevention of Epidermolysis Bullosa
Application:
17/863,964 →
Publication:
US 2023/0142060
Systems and Methods for Patient Stratification and Identification of Potential Biomarkers
Application:
17/953,075 →
Publication:
US 2023/0274799
Methods of Treatment of Cancer by Continuous Infusion of Coenzyme Q10
Application:
17/962,608 →
Publication:
US 2023/0285272
Preventing or Mitigating Chemotherapy Induced Alopecia Using Vitamin D
Application:
17/981,038 →
Publication:
US 2023/0302022
Interrogatory Cell-Based Assays and Uses Thereof
Application:
18/125,524 →
Publication:
US 2024/0062844
Interrogatory Cell-Based Assays for Identifying Drug-Induced Toxicity Markers
Application:
18/197,673 →
Publication:
US 2024/0161863
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 19, 2012
From: BERG BIOSYSTEMS, LLC
To: BERG PHARMA LLC
Reel/Frame 028590/0308 →
Assignment of Assignor's Interest
Jul 24, 2012
From: NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD; VISHNUDAS, VIVEK K.
To: BERG PHARMA LLC
Reel/Frame 028624/0644 →
Change of Name
Oct 29, 2015
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 036991/0810 →
Change of Name
Oct 29, 2015
From: CYTOTECH LABS, LLC
To: BERG THERAPEUTICS, LLC
Reel/Frame 037023/0233 →
Change of Name
Oct 29, 2015
From: BERG THERAPEUTICS, LLC
To: BERG PHARMA LLC
Reel/Frame 036991/0778 →
Change of Name
Dec 4, 2015
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 037218/0558 →
Assignment of Assignor's Interest
Jun 1, 2016
From: NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD
To: BERG LLC
Reel/Frame 038760/0199 →
Assignment of Assignor's Interest
Dec 14, 2017
From: NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD; GRAY, THOMAS MITCHELL; MCCOOK, JOHN PATRICK
To: BERG LLC
Reel/Frame 044398/0505 →
Assignment of Assignor's Interest
Apr 19, 2022
From: KIEBISH, MICHAEL ANDREW; SHAH, PUNIT; NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD
To: BERG LLC
Reel/Frame 059642/0795 →
Assignment of Assignor's Interest
Apr 19, 2022
From: KIEBISH, MICHAEL ANDREW; SHAH, PUNIT; NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD
To: BERG LLC
Reel/Frame 059642/0787 →
Assignment of Assignor's Interest
Apr 19, 2022
From: KIEBISH, MICHAEL ANDREW; SHAH, PUNIT; NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD
To: BERG LLC
Reel/Frame 059642/0776 →
Assignment of Assignor's Interest
Dec 16, 2022
From: VISHNUDAS, VIVEK K.
To: BERG LLC
Reel/Frame 062122/0882 →
Assignment of Assignor's Interest
Sep 25, 2023
From: HU, HAI
To: WINDBER RESEARCH INSTITUTE
Reel/Frame 065008/0146 →
Assignment of Assignor's Interest
Sep 25, 2023
From: HU, HAI
To: WINDBER RESEARCH INSTITUTE
Reel/Frame 065008/0167 →
Assignment of Assignor's Interest
Sep 25, 2023
From: HU, HAI
To: WINDBER RESEARCH INSTITUTE
Reel/Frame 065008/0188 →
Assignment of Assignor's Interest
Sep 26, 2023
From: CAMPBELL, JAMIE LEIGH
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 065027/0300 →
Assignment of Assignor's Interest
Sep 26, 2023
From: UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 065028/0513 →
Assignment of Assignor's Interest
Sep 26, 2023
From: SHRIVER, CRAIG
To: UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
Reel/Frame 065028/0485 →
Assignment of Assignor's Interest
Sep 26, 2023
From: CUTLER, MARY LOU
To: UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
Reel/Frame 065028/0482 →
Assignment of Assignor's Interest
Sep 26, 2023
From: CUTLER, MARY LOU
To: UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
Reel/Frame 065028/0449 →
Assignment of Assignor's Interest
Sep 26, 2023
From: SHRIVER, CRAIG
To: UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
Reel/Frame 065028/0429 →
Assignment of Assignor's Interest
Sep 26, 2023
From: HOOKE, JEFFREY A.
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 065027/0675 →
Assignment of Assignor's Interest
Sep 26, 2023
From: KOVATICH, ALBERT JOHN
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 065027/0617 →
Assignment of Assignor's Interest
Sep 26, 2023
From: WANG, GUISONG
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 065027/0584 →
Assignment of Assignor's Interest
Sep 26, 2023
From: HOOKE, JEFFREY A.
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 065027/0528 →